Evidence map›Paper›PMID 16552053›Full record

ArticleInfection and immunity2006

Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid.

Galyna Afonina, Isabelle Leduc, Igor Nepluev, Chrystina Jeter, Patty Routh, Glen Almond, Paul E Orndorff, Marcia Hobbs, Christopher Elkins

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 45 citations in OpenAlex.

  1. A Class IInfection and immunity · 2019
    Trial
  2. Molecular pathogenesis ofMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  3. Infections caused byClinical microbiology reviews · 2024
    Review
  4. Pirates of the haemoglobin.Microbial cell (Graz, Austria) · 2022
    Review
  5. Article
  6. Article
  7. Heat shock enhances outer-membrane vesicle release inCurrent research in microbial sciences · 2021
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Host-pathogen interplay of Haemophilus ducreyi.Current opinion in infectious diseases · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Galyna AfoninaDepartment of Medicine, School of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA. afonina@email.unc.edu
Isabelle Leduc
Igor Nepluev
Chrystina Jeter
Patty Routh
Glen Almond
Paul E Orndorff
Marcia Hobbs
Christopher Elkins
North Carolina State University · USUniversity of North Carolina at Chapel Hill · US

Funding

SCIENTIFIC, TECHNICAL AND LOGISTICS SUPPORT FOR DEAN01AI005393 · NIAID · LTS CORPORATION · PI VAN BRUNT, VIRGINIA · 2000 to 2000
$3.9M
NIAID NIH HHS 5-R01-AI 05393NIAID NIH HHS N01 AI005393
6 · The paper itself

Abstract

The etiologic agent of chancroid is Haemophilus ducreyi. To fulfill its obligate requirement for heme, H. ducreyi uses two TonB-dependent receptors: the hemoglobin receptor (HgbA) and a receptor for free heme (TdhA). Expression of HgbA is necessary for H. ducreyi to survive and initiate disease in a human model of chancroid. In this study, we used a swine model of H. ducreyi infection to demonstrate that an experimental HgbA vaccine efficiently prevents chancroid, as determined by several parameters. Histological sections of immunized animals lacked typical microscopic features of chancroid. All inoculated sites from mock-immunized pigs yielded viable H. ducreyi cells, whereas no viable H. ducreyi cells were recovered from inoculated sites of HgbA-immunized pigs. Antibodies from sera of HgbA-immunized animals bound to and initiated antibody-dependent bactericidal activity against homologous H. ducreyi strain 35000HP and heterologous strain CIP542 ATCC; however, an isogenic hgbA mutant of 35000HP was not killed, proving specificity. Anti-HgbA immunoglobulin G blocked hemoglobin binding to the HgbA receptor, suggesting a novel mechanism of protection through the limitation of heme/iron acquisition by H. ducreyi. Such a vaccine strategy might be applied to other bacterial pathogens with strict heme/iron requirements. Taken together, these data suggest continuing the development of an HgbA subunit vaccine to prevent chancroid.

Indexed as

SwineAnimalsAntibodies, BacterialBacterial ProteinsBinding Sites, AntibodyCarrier ProteinsChancroidDisease Models, AnimalHaemophilus ducreyiHaemophilus VaccinesHemoglobinsImmunoglobulin GProtein BindingAntibodies, BacterialBacterial ProteinsCarrier ProteinsHaemophilus Vaccineshemoglobin-binding protein, bacteriaHemoglobinsImmunoglobulin G

Identifiers

PMID16552053
PMCPMC1418891
OpenAlexW2158304670

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.